Bioterrorism and the nervous system

Current Neurology and Neuroscience Reports

Volumn 3, Issue 6, 2003, Pages 476-482

  Han, M H ^a   Zunt, J R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE; BOTULINUM ANTISERUM; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN E; CHLORAMPHENICOL; CIDOFOVIR; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; IMMUNOGLOBULIN; OFLOXACIN; PENICILLIN G; RIFAMPICIN; SMALLPOX VACCINE; STEROID; STREPTOMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT; VIRUS VACCINE;

ANTHRAX; ARTIFICIAL VENTILATION; AWARENESS; BACILLUS ANTHRACIS; BACKACHE; BIOLOGICAL WARFARE; BOTULISM; BRAIN EDEMA; BRUCELLOSIS; CARDIOVASCULAR DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DELIRIUM; DEMYELINATION; DISEASE TRANSMISSION; DOSE RESPONSE; EARLY DIAGNOSIS; ECZEMA; ENCEPHALITIS; ENCEPHALOMYELITIS; ERYTHEMA MULTIFORME; HEADACHE; HEALTH PRACTITIONER; HUMAN; MEDICAL SPECIALIST; MENINGITIS; MENINGOENCEPHALITIS; NEUROLOGIC DISEASE; OPTIC NERVE DISEASE; PHYSICIAN ATTITUDE; PLAGUE; POSTAL MAIL; PSYCHOSIS; REVIEW; SEIZURE; SMALLPOX; TERRORISM; TULAREMIA; UNITED STATES; VACCINIA; WAR; MICROBIOLOGY;

ANTHRAX; ANTI-BACTERIAL AGENTS; BIOTERRORISM; BOTULISM; BRUCELLOSIS; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; HUMANS; NERVOUS SYSTEM DISEASES; PLAGUE; SMALLPOX; VIRAL VACCINES;

EID: 1542599106     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-003-0050-9     Document Type: Review

References (50)

1. History of Bioterrorism: http://bcrc.bio.umass.edu/phpwiki/index.php/HistoryOfBioterrorism. Accessed on June 1, 2002.
2. History of Biowarfare: http://www.usamriid.army.mil/education/bluebook.html. Accessed on June 1, 2002.
3. Bioterrorism preparedness and response program: http://www.bt.cdc.gov/index.asp. Accessed on June 1, 2002.
4. Suffin SC, Carnes WH, Kauffman AF: Inhalation anthrax in a home craftsman. Hum Pathol 1978, 9:594-597.
5. Update: Investigation of bioterrorism-related anthrax, 2001. Morb Mortal Wkly Rep 2001, 50:1008-1010.
6. Franz DR, Jahrling PB, McClain DJ, et al.: Clinical recognition and management of patients exposed to biological warfare agents. Clin Lab Med 2001, 21:435-473.
7. Lanska DJ: Anthrax meningoencephalitis. Neurology 2002, 59:327-334.
8. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH: Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A 1993, 90:2291-2294.
9. Jernigan JA, Stephens DS, Ashford DA, et al.: Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001, 7:933-944.
10. Haight TH: Anthrax meningitis: review of literature and report of two cases with autopsies. Am J Med Sci 1952, 224:57-69.
11. Tabatabaie P, Syadati A: Bacillus anthracis as a cause of bacterial meningitis. Pediatr Infect Dis J 1993, 12:1035-1037.
12. Kim HJ, Jun WB, Lee SH, Rho MH: CT and MR findings of anthrax meningoencephalitis: report of two cases and review of the literature. Am J Neuroradiol 2001, 22:1303-1305.
13. Pluot M, Vital C, Aubertin J, et al.: Anthrax meningitis. Report of two cases with autopsies. Acta Neuropathol (Berl) 1976, 36:339-345.
14. Penn CC, Klotz SA: Anthrax pneumonia. Semin Respir Infect 1997, 12:28-30.
15. Bell DM, Kozarsky PE, Stephens DS: Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg Infect Dis 2002, 8:222-225.
16. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. Morb Mortal Wkly Rep 2001, 50:941-948.
17. Nass M: The Anthrax Vaccine Program: an analysis of the CDC's recommendations for vaccine use. Am J Public Health 2002, 92:715-721.
18. Use of anthrax vaccine in the United States. MMWR Recomm Rep 2000, 49:1-20.
19. Kerrison JB, Lounsbury D, Thirkill CE, et al.: Optic neuritis after anthrax vaccination. Ophthalmology 2002, 109:99-104.
20. Jenner E: An inquiry into the causes and effects of the variolae vacciniae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of cowpox. London: Samson Low, 1798.
21. Fenner F, Henderson DA, Arita I, et al.: Smallpox and Its Eradication. Geneva: World Health Organization; 1988.
22. Alibek K: Biohazard. New York: Random House, 1999.
23. Downie AW, Meiklejohn M, St Vincent L, et al.: The recovery of smallpox virus from patients and their environment in a smallpox hospital. Bull World Health Org 1965, 33:615-622.
24. Cleri DJ, Villota H, Porwancher RB: Smallpox, bioterrorism, and the neurologist. Arch Neurol 2003, 60:489-494.
25. Borio L, Inglesby T, Peters CJ, et al.: Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002, 287:2391-2405.
26. Marsden JP, Hurst EW: Acute perivascular myelinoclasis in smallpox. Brain 1932, 55:181-225.
27. Ropp SL, Jin Q, Knight JC, et al.: PCR strategy for identification and differentiationof small pox and other orthopoxviruses. J Clin Microbiol 1995, 33:2069-2076.
28. Bartlett L Borio L, Radonovich L, et al.: Smallpox vaccination in 2003: key information for clinicians. Clin Infect Dis 2003, 36:883-902.
29. Roos KL, Eckerman NL: The smallpox vaccine and postvaccinal encephalitis. Semin Neurol 2002, 22:95-98.
30. Cardiac adverse events following smallpox vaccination--United States, 2003. Morb Mortal Wkly Rep 2003, 52:248-250.
31. Inglesby TV, Dennis DT, Henderson DA, et al.: Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 2000, 283:2281-2290.
32. Harris SH Factories of Death. New York: Routledge, 1994.
33. Becker TM, Polland JD, Quan TJ et al.: Plague meningitis - a retrospective analysis of cases reported in the United States, 1970-1979. West J Med 1987, 147:554-557.
34. Butler T: Yersinia species (including plague). In Principles and Practice of Infectious Diseases. Edited by Dolin T. New York: Churchill Livingstone; 1995: 2070-2078.
35. MacDonald KL, Cohen ML, Blake PA: The changing epidemiology of adult botulism in the United States. Am J Epidemiol 1986, 124:794-799.
36. Weber JT, Hibbs RG Jr, Darwish A, et al.: A massive outbreak of type E botulism associated with traditional salted fish in Cairo. J Infect Dis 1993, 167:451-454.
37. Hughes JM, Blumenthal JR, Merson MH, et al.: Clinical features of types A and B food-borne botulism. Ann Intern Med 1981, 95:442-445.
38. United States Public Health Services: Botulism in the United States, 1899-1973: Handbook for Epidemiologists, Clinicians and Laboratory Workers. Atlanta: US Dept. of Health, Education and Welfare; 1974.
39. Woodruff BA, Griffin PM, McCroskey LM, et al.: Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988. J Infect Dis 1992, 166:1281-1286.
40. Beck CG, Wyckof RW: Venezuelan equine encephalitis. Science 1938, 88:530.
41. Johnson KM, Martin DH: Venezuelan equine encephalitis. Adv Vet Sci Comp Med 1974, 18:79-116.
42. Coates DM, Makh SR, Jones N, Lloyd G: Assessment of assays for the serodiagnosis of Venezuelan equine encephalitis. J Infect 1992, 25:279-289.
43. Corbel MJ: Brucellosis: epidemiology and prevalence worldwide. In Brucellosis: Clinical and Laboratory Aspects. Edited by Corbel ML Boca Raton, FL: CRC Press; 1989:25-40.
44. Buchanan TM, Hendricks SL, Patton CM, Feldman RA: Brucellosis in the United States, 1960-1972; an abattoir-associated disease. Part III. Epidemiology and evidence for acquired immunity. Medicine 1974, 53:427-439.
45. Lulu AR, Araj GF, Khateeb MI et al.: Human brucellosis in Kuwait: a prospective study of 400 cases. Q J Med 1988, 66:39-54.
46. Mousa AR, Elhag KM, Khogali M, Marafie AA: The nature of human brucellosis in Kuwait: study of 379 cases. Rev Infect Dis 1988, 10:211-217.
47. Shakir RA, Al-Din AS, Araj GF, et al.: Clinical categories of neurobrucellosis. A report on 19 cases. Brain 1987, 110:213-223.
48. Larbrisseau A, Maravi E, Aguilera F, Martinez-Lage JM: The neurological complications of brucellosis. Can J Neurol Sci 1978, 5:369-376.
49. McLean DR, Russell N, Khan MY: Neurobrucellosis: clinical and therapeutic features. Clin Infect Dis 1992, 15:582-590.
50. Ferguson NE, Steele L, Crawford CY, et al.: Bioterrorism web site resources for infectious disease clinicians and epidemiologists. Clin Infect Dis 2003, 36:1458-1473.